Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00939770
Title Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Children's Oncology Group
Indications

Advanced Solid Tumor

anaplastic large cell lymphoma

central nervous system cancer

neuroblastoma

Therapies

Crizotinib

Age Groups: adult | child
Covered Countries USA | CAN

Additional content available in CKB BOOST